Evidence supporting the use of: Methylcobalamin Dicalcium Phosphate
For the health condition: Pernicious Anemia
Synopsis
Source of validity: Scientific
Rating (out of 5): 4
Methylcobalamin is a biologically active form of vitamin B12, which is essential for red blood cell formation and neurological function. Pernicious anemia is a condition caused by vitamin B12 deficiency, most commonly due to impaired absorption resulting from lack of intrinsic factor. Scientific evidence strongly supports the use of vitamin B12 supplementation, including methylcobalamin, as a treatment for pernicious anemia. While cyanocobalamin is the standard form used in most clinical settings, methylcobalamin is also effective and may be preferred in some cases due to its bioavailability and direct usability by the body. Multiple studies and authoritative guidelines recommend vitamin B12 supplementation as the cornerstone of pernicious anemia management.
Dicalcium phosphate, on the other hand, serves as an inactive excipient—meaning it is used as a filler or binder in tablets and does not play a therapeutic role in treating pernicious anemia. It is not an active ingredient for anemia treatment. The therapeutic benefit is solely due to methylcobalamin.
In summary, the use of methylcobalamin to treat pernicious anemia is supported by strong scientific evidence, with the caveat that the form (methyl or cyano) may vary based on local guidelines and patient needs. Dicalcium phosphate is present only as a tablet component and does not contribute to anemia treatment.
More about Methylcobalamin Dicalcium Phosphate
More about Pernicious Anemia
Other ingredients used for Pernicious Anemia
bovine kidneybovine liver
bovine spleen
vitamin B12
Animal Tissue
Beef
Beef liver
Other health conditions supported by Methylcobalamin Dicalcium Phosphate
AnemiaFatigue
Peripheral Neuropathy
Pernicious Anemia